Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

8 Biotechnology Stocks to Sell Now

This week, the overall grades of eight Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Crummy Earnings Growth — WTSL KWK GNK SOL CRK

This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Worst Sectors to Avoid This Week

According to the Portfolio Grader database this week, the Metals and Mining, Computer and Personal Electronics, Oil and Gas, Energy Services, and Semiconductor sectors are at the bottom.

5 Stocks With Ugly Cash Flow — KWK STP ATPG EDN AONE

This week, these five stocks have the worst ratings in Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Poor Operating Margin Growth — PGNX SYUT CTEL HKTV IMMU

This week, these five stocks have the worst ratings in Operating Margin Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Bad Sales Growth — NAVB CTEL HKTV CUR IMMU

This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.

4 Capital Markets Stocks to Sell Now

For the current week, the overall ratings of four Capital Markets stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Media Stocks to Sell Now

This week, the ratings of three Media stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Should I Buy Dell? 3 Pros, 3 Cons

With a Dell buyout a foregone conclusion, is the stock dead money -- or is there something more to be squeezed out of these shares?

3 Medical Devices Stocks to Sell Now

The ratings of three Medical Devices stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

2 Technically Disintegrating Stocks to Avoid or Short

These two well-known stocks have struggled to maintain technical integrity lately -- an indication that they'll suffer dramatically when the market corrects.

5 Internet and Web Service Stocks to Sell Now

The ratings of five Internet and Web Service stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Crummy Analyst Earnings Revisions — BONT VRTX PSEM TRNX UEC

This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.

12 “Triple F” Stocks to Sell

This week, 12 stocks get F's ("strong strong") in Portfolio Grader's three main grading categories, Total Grade, Overall Fundamental Grade, and Quantitative Grade.

16 Oil and Gas Stocks to Sell Now

The overall ratings of 16 Oil and Gas stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Facebook Stock Has Peaked: The Ifs, Ands & Buts

It might seem a fool's errand to bet against Mark Zuckerberg now that he's shown adaptability, but Facebook probably won't do much more for investors ... at least in the near-term.

5 Electrical Equipment Stocks to Sell Now

This week, the ratings of five Electrical Equipment stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Chemicals Stocks to Sell Now

The overall ratings of four Chemicals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Pharmaceutical Stocks to Sell Now

This week, the overall grades of three Pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").